[Studies on the uricosuric action of Azapropazone].
D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D002940:Circadian Rhythm; D003404:Creatinine / Q000652:urine; D005919:Glomerular Filtration Rate; D006073:Gout / Q000188:drug therapy; D006801:Humans; D007684:Kidney Tubules / Q000187:drug effects*; D008314:Malonates / Q000037:antagonists & inhibitors / Q000494:pharmacology; D008744:Methylamines / Q000037:antagonists & inhibitors / Q000494:pharmacology; D008875:Middle Aged; D010113:Oxyphenbutazone / Q000008:administration & dosage / Q000494:pharmacology; D011718:Pyrazinamide / Q000494:pharmacology; D014227:Triazines / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D014527:Uric Acid / Q000097:blood*; D014528:Uricosuric Agents
D000893:Anti-Inflammatory Agents; D008314:Malonates; D008744:Methylamines; D014227:Triazines; D014528:Uricosuric Agents; D014527:Uric Acid; D011718:Pyrazinamide; D003404:Creatinine; D010113:Oxyphenbutazone
Untersuchungen zur urikosurischen Wirkung von Azapropazon.